New injection aims to restore swallowing in rare muscle disease
NCT ID NCT06185673
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a single injection of BB-301 directly into throat muscles to improve swallowing in people with oculopharyngeal muscular dystrophy (OPMD). About 30 adults aged 50-65 with swallowing problems will receive the injection during a short surgery. Researchers will check safety and measure how well the treatment reduces food sticking in the throat.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULOPHARYNGEAL MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.